Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Benign Hematology
•
Von Willebrand
How do you manage bleeding or peri-procedural care for vWD patients whose vWF levels have increased or normalized from age or hormonal contraceptive use?
How do you think about removing the vWD diagnosis if levels have normalized from age?
Related Questions
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
How do you manage a subchorionic hematoma in type 1 von Willebrand disease, with borderline normal levels of vWF?
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
Can lupus anticoagulant be positive despite a normal aPTT?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How quickly do you expect iron stores to decrease after starting iron chelators?